Dr. Elyse Joy Singer, MD

Dr. Singer practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Singer's NPI, 1528085099, was assigned on July 17, 2006. Dr. Singer graduated from Frederick P. Whiddon College of Medicine in 1978. Dr. Singer's California license number on file is G39859.

Dr. Singer's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Singer's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Singer is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Singer to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singer practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Singer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Singer is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Singer has a license on file in California.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache, neuropathy and thoracic spine disorders among the conditions Dr. Singer treats.

CMS data shows 50 Medicare services from Dr. Singer across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $5,817 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Dr. Singer in 2024. The largest group is 65 to 74, with 16 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 33% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singer's median patient age at 61, with 51% women.

In 2024, Dr. Singer wrote 174 Medicare Part D claims for 23 patients. 98% of them were for generic drugs. CMS names the drug for 125 of them, across 6 drugs with 11 or more claims each, at $3,019 in total drug cost. In 2023, CMS named 176 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Singer for performance year 2024, reported as part of a group. Dr. Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singer as offering telehealth.

Dmand AI links 5 papers to Dr. Singer, published from 2011 to 2014. 2013 was the busiest year, with 2. Dr. Singer's most frequent co-authors are Ronald L. Cohen, MD, Eric S. Daar, MD and Laura Bonelli, MD.

Dmand AI lists 1 award for Dr. Singer.

Dr. Singer graduated from Frederick P. Whiddon College of Medicine in 1978. Dr. Singer is a member of AAN.

Dr. Singer is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.